¶ acute inflammatory response
¶ Definition
The orchestrated, time-sensitive cellular and vascular cascade triggered by tissue damage or pathogen invasion, involving sequential recruitment of immune cells, coordinated cytokine signaling, and vascular permeability changes. This response proceeds through three distinct phases—alarm (0-6 hours), amplification (6-24 hours), and early resolution (24-72 hours)—and is essential for healing, tissue repair, and return to homeostasis. Suppression of this response predicts chronic pain and failed tissue recovery.
¶ Picture It
Imagine a five-alarm fire in a city building. Within minutes, the alarm phase triggers: smoke detectors (DAMPs) sound, and the first responders—fire trucks (neutrophils) and hazmat crews (macrophages)—arrive. The street captain (mast cells) releases traffic cones and flares (histamine) to widen access routes (vasodilation). The amplification phase follows: more units roll in as the fire chief (IL-6, TNF-α) broadcasts urgent calls across police radios (cytokine signaling). Traffic cops (endothelial cells) put up detour signs (E-selectin, ICAM-1) so firefighters can park exactly where needed. By hour 24, the flames are out, and the resolution phase begins: cleanup crews (specialized pro-resolving mediators) arrive to haul debris, repair water damage, and restore normal traffic flow.
If you suppress the alarm—imagine blocking the smoke detectors or handcuffing the fire chief—the building smolders uncontrolled. Small fires keep reigniting in hidden corners (chronic inflammation), the structure weakens (fibrosis), and what could have been a quick repair turns into demolition (chronic pain). The acute inflammatory response is the city's functional emergency system—you don't suppress it, you let it finish its job.
¶ Mechanism
The acute inflammatory response follows a highly conserved molecular cascade:
¶ Alarm Phase (0-6 hours)
- Tissue damage releases intracellular contents (ATP, HMGB1, mitochondrial DNA) → recognized as DAMPs by pattern recognition receptors (TLR4, TLR9, NLRP3)
- Resident mast cells degranulate → release preformed histamine, serotonin, TNF-α → binds H1 receptors on endothelial cells → increased vascular permeability and vasodilation
- Tissue-resident macrophages (M0 phenotype) detect DAMPs via TLR4 → activate NF-κB transcription factor → rapidly synthesize and secrete early cytokines:
- TNF-α (peaks 1-2 hours post-injury)
- IL-1β (requires NLRP3 inflammasome activation)
- IL-6 (dual-function cytokine, peaks 2-6 hours)
- Endothelial cells upregulate adhesion molecules:
¶ Amplification Phase (6-24 hours)
- Circulating neutrophils undergo three-step recruitment:
- Rolling: P-selectin/E-selectin bind neutrophil PSGL-1 and sialyl-Lewis^x
- Adhesion: IL-8 (CXCL8) activates neutrophil β2-integrins (LFA-1, Mac-1) → firm binding to ICAM-1
- Extravasation: neutrophils transmigrate through endothelial junctions (PECAM-1-mediated)
- Neutrophils phagocytose debris, release reactive oxygen species (respiratory burst via NADPH oxidase), and degranulate proteases (elastase, cathepsin G)
- Monocytes are recruited (CCL2/MCP-1 gradient) → differentiate into M1 macrophages in tissue
- Prostaglandin E2 (PGE2) synthesis:
- Membrane phospholipids → arachidonic acid (via phospholipase A2) → COX-2 → PGE2
- PGE2 binds EP receptors on nociceptors → sensitization (hyperalgesia)
- PGE2 also signals tissue damage systemically
- Liver responds to circulating IL-6 → hepatocyte STAT3 activation → synthesis of acute phase proteins:
- C-reactive protein (CRP, >10 mg/L indicates active inflammation)
- Serum amyloid A
- Fibrinogen
- Hepcidin (sequesters iron from pathogens)
- Complement system activation (classical, alternative, lectin pathways) → C3a, C5a anaphylatoxins amplify immune cell recruitment
¶ Early Resolution Phase (24-72 hours)
- Lipid mediator class switching:
- COX-2 acetylation by aspirin (if given) → produces aspirin-triggered lipoxins (ATL)
- 15-LOX and 5-LOX generate lipoxins (LXA4, LXB4) from arachidonic acid
- DHA → resolvins (RvD1-6), protectins, maresins
- EPA → E-series resolvins (RvE1-3)
- Specialized pro-resolving mediators bind specific receptors:
- RvD1 → ALX-FPR2 receptor, GPR32 → stops neutrophil recruitment
- RvE1 → ChemR23, BLT1 → enhances macrophage efferocytosis
- Macrophages shift to M2 phenotype (IL-4, IL-13 signaling):
- Upregulate efferocytosis machinery (MerTK, CD36)
- Secrete TGF-beta, IL-10 (anti-inflammatory)
- Promote fibroblasts → collagen deposition (tissue repair)
- Neutrophils undergo apoptosis → cleared by M2 macrophages
- Vascular permeability normalizes, edema resolves
graph TD
A[Tissue Damage] -->|DAMPs| B[Mast Cell Degranulation]
A -->|DAMPs| C[Macrophage TLR4 Activation]
B -->|Histamine| D["Vasodilation + Permeability"]
C -->|"NF-κB"| E["TNF-α, IL-1β, IL-6"]
E -->|Cytokine Signaling| F[Endothelial Adhesion Molecules]
F -->|E-selectin, ICAM-1| G[Neutrophil Rolling & Adhesion]
G -->|IL-8 Gradient| H[Neutrophil Extravasation]
H --> I[Phagocytosis, ROS, Proteases]
C -->|COX-2 Induction| J[PGE2 Production]
J -->|EP Receptors| K[Pain Sensitization]
E -->|IL-6 to Liver| L[Acute Phase Proteins]
I -->|24-48h| M[Lipid Mediator Class Switch]
M -->|15-LOX, 5-LOX| N[Lipoxins, Resolvins, Protectins]
N -->|ALX-FPR2, ChemR23| O[M2 Macrophage Polarization]
O -->|Efferocytosis| P[Neutrophil Clearance]
O -->|"TGF-β, IL-10"| Q[Tissue Repair & Resolution]
¶ NSAID Interference
- NSAIDs block COX-1 and COX-2 → prevent prostaglandins synthesis
- Without PGE2 signal, immune cell recruitment is blunted
- Neutrophil % drops → predicts chronic pain development
- SPM synthesis is delayed (COX-2 needed for lipoxin/resolvin precursors)
- Result: incomplete debris clearance, persistent low-grade inflammation
¶ Clinical Significance
EXAM KEY: The acute inflammatory response is protective, not pathological. Clinical practice must shift from suppression to support.
¶ Patient Populations
- Acute injury patients (sprains, fractures, muscle tears): Robust inflammatory response in first 72 hours predicts pain resolution by 6 months
- Post-surgical recovery: Early NSAID use correlates with delayed bone healing, impaired collagen remodeling
- Chronic pain patients: Retrospective analysis shows initial NSAID suppression of acute inflammation in 70-80% of cases
- Autoimmune flares: Distinguish acute response (protective) from chronic inflammation (pathological)
¶ Metamodel Connections
- 5 plus 2 metamodel: Acute inflammation is a physiological reaction to legitimate tissue damage—not a disease state requiring suppression
- selfish immune system: The immune system prioritizes pathogen defense and tissue repair over comfort—pain is a protective signal
- evolutionary mismatch: Modern medicine treats inflammation as the enemy; ancestral injuries healed through robust acute response without pharmaceutical intervention
¶ Clinical Thresholds
- Neutrophil count: Should rise 2-3× baseline in first 24 hours post-injury (normal baseline 2.5-7.5 × 10⁹/L)
- IL-6: Peaks at 20-100 pg/mL in healthy acute response (baseline <5 pg/mL)
- CRP: Rises to 10-50 mg/L by 24-48 hours (baseline
mg/L) - Recovery predictor: Neutrophil % inversely correlates with chronic pain at 6 months (lower early neutrophils = higher chronic pain risk)
¶ Intervention Implications
- Avoid early NSAIDs (first 48-72 hours post-injury)
- Exception: Severe allergic reactions, autoimmune crisis
- Support resolution instead of suppression:
- Omega-3 supplementation (EPA/DHA 2-4 g/day) → SPM substrate
- Curcumin 500-1000 mg/day → enhances M2 polarization without blocking COX-2
- Adequate sleep (7-9 hours) → melatonin supports macrophage efferocytosis
- Protein intake (1.2-1.6 g/kg) → substrate for tissue repair
- Topical interventions:
- Ice (10-15 min/hour first 6 hours) → vasoconstriction limits edema without blocking cytokines
- Compression → mechanical support of damaged tissue
- Elevation → reduces hydrostatic pressure
- Allow pain as signal: Pain indicates tissue damage extent—analgesic should not fully mask this (use paracetamol if needed, not NSAIDs)
¶ Red Flags for Clinician
- Blunted response: Low WBC, absent fever, minimal swelling post-injury → suspect immunosuppression (corticosteroids, malnutrition, chronic stress)
- Excessive response: Neutrophil count >15 × 10⁹/L, CRP >100 mg/L → suspect infection, not sterile injury
- Prolonged acute phase (>7 days elevated CRP) → transition to chronic inflammation, investigate underlying cause
¶ Key Facts
- Recovery group (no chronic pain) shows robust activation of T cells, macrophages, NK cells, monocytes, dendritic cells, neutrophils, eosinophils, B cells in first 72 hours
- Neutrophil percentage at 24-48 hours inversely predicts chronic pain development at 6 months (lower neutrophils = higher chronic pain risk)
- Cytokine cascade timing: TNF-α peaks at 1-2 hours, IL-1β at 2-4 hours, IL-6 at 4-6 hours post-injury
- PGE2 is both pro-inflammatory (pain sensitization) and pro-resolving (needed for SPM synthesis via COX-2 acetylation)
- NSAIDs block: COX-1 (constitutive) and COX-2 (inducible) → prevent prostaglandin synthesis → suppress neutrophil recruitment and SPM production
- Acute phase duration: 24-72 hours in healthy, well-nourished individuals; may extend to 96 hours in elderly or malnourished
- Lipid mediator switch: Occurs at 12-24 hours post-injury when 15-LOX and 5-LOX activity overtakes COX-2 dominance
- M1 to M2 macrophage shift: Begins at 24-48 hours, peaks at 72-96 hours, driven by lipoxins and resolvins
- Complement C5a: Potent neutrophil chemoattractant, peaks at 1-6 hours, cleaved from C5 by convertases
- IL-6 dual role: Pro-inflammatory in acute phase (STAT3 activation), anti-inflammatory in resolution (induces IL-10, suppresses TNF-α)
- Endothelial adhesion molecules: P-selectin appears in minutes (prestored), E-selectin in 2-4 hours (transcribed), ICAM-1/VCAM-1 in 4-6 hours (NF-κB dependent)
- Mast cell mediators: Histamine (immediate), TNF-α (preformed and newly synthesized), heparin (anticoagulant), tryptase (activates PAR-2 on nociceptors)
¶ Connections
- acute inflammation — synonymous term, same biological cascade
- neutrophils — first-line phagocytic cells, arrive 0-6 hours, percentage predicts recovery
- macrophages — dual role: M1 (pro-inflammatory, 6-24h) and M2 (pro-resolving, 24-72h)
- mast cells — initiate alarm phase via histamine and preformed TNF-α degranulation
- cytokines — molecular coordinators: TNF-α, IL-1β, IL-6 orchestrate entire cascade
- IL-6 — pleiotropic acute phase cytokine, signals liver for acute phase protein synthesis
- TNF-α — earliest cytokine (1-2h peak), activates endothelial NF-κB and adhesion molecules
- IL-1β — requires NLRP3 inflammasome, synergizes with TNF-α for amplification
- prostaglandins — lipid mediators from COX-2, essential for pain signaling and SPM precursors
- PGE2 — binds EP receptors on nociceptors (pain), also substrate for resolvin synthesis
- COX-2 — inducible enzyme, produces PGE2, later acetylated for lipoxin/resolvin synthesis
- NSAIDs — block COX-1/COX-2, suppress beneficial acute response, predict chronic pain
- adhesion molecules — E-selectin, P-selectin, ICAM-1, VCAM-1 enable neutrophil extravasation
- endothelial cells — vascular gatekeepers, upregulate adhesion molecules in response to TNF-α and IL-1β
- leukocytes — umbrella term for all white blood cells recruited during acute response
- NF-κB — master transcription factor for pro-inflammatory cytokines, activated by TLR4 and TNF-α
- DAMPs — intracellular alarmins (HMGB1, ATP, mtDNA) released by damaged cells, trigger TLRs
- TLR4 — pattern recognition receptor on macrophages, senses DAMPs and LPS
- specialized pro-resolving mediators — lipoxins, resolvins, protectins, maresins switch off acute response
- resolution of inflammation — active process (24-72h), mediated by SPMs and M2 macrophages
- wound healing — acute inflammatory response is necessary first phase, followed by proliferation and remodeling
- chronic pain — develops when acute inflammatory response is suppressed (NSAID use, malnutrition, immunosuppression)
- liver — synthesizes acute phase proteins (CRP, SAA, fibrinogen) in response to IL-6
- acute phase proteins — CRP, serum amyloid A, hepcidin, fibrinogen, secreted by liver during acute response
- complement system — amplifies acute response via C3a and C5a anaphylatoxins, opsonizes debris
- fibroblasts — recruited in resolution phase by M2 macrophages, deposit collagen for tissue repair
- arachidonic acid — omega-6 fatty acid, substrate for both prostaglandins (via COX-2) and lipoxins (via 15-LOX)
- 15-LOX — enzyme that produces lipoxins from arachidonic acid during resolution phase
- 5-LOX — produces leukotrienes (pro-inflammatory) early, then resolvins (pro-resolving) later
- resolvins — specialized pro-resolving mediators from EPA (E-series) and DHA (D-series)
- efferocytosis — M2 macrophage phagocytosis of apoptotic neutrophils, essential for resolution
- TGF-beta — anti-inflammatory cytokine secreted by M2 macrophages, promotes fibroblast collagen synthesis
- IL-10 — anti-inflammatory cytokine, suppresses TNF-α and IL-1β, secreted by M2 macrophages and Tregs
¶ Module References
- Module 1 — Acute inflammatory response as protective mechanism, NSAID suppression as risk factor for chronic pain
- Module 5 — Immune cell dynamics, cytokine cascade, lipid mediator class switching, resolution pharmacology